Antiphospholipid antibodies and the antiphospholipid syndrome: Clinical relevance in neuropsychiatric systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 823, Issue , 1997, Pages 279-288

  Alarcón Segovia, Donato ^a   Estañol, Bruno ^a   García Ramos, Guillermo ^a   Villa, Antonio R ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CHOREA; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; MYELITIS; NEUROLOGICAL COMPLICATION; NEUROPSYCHIATRY; PERIPHERAL NEUROPATHY; PSYCHOSIS; REGRESSION ANALYSIS; SEIZURE; SNEDDON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT ISCHEMIC ATTACK;

EID: 0030769962     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48401.x     Document Type: Conference Paper

References (32)

1. HARRIS, E. N. 1984. Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies. Clin. Exp. Rheumatol. 2: 47-51.
2. ASHERSON, R. A. et al. 1989. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid antibody syndrome. Am. J. Med. 86: 391-399.
3. LEVINE, S. R. et al. 1987. Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. Stroke 18: 801-804.
4. LEVINE, S. R. et al 1987. Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia 7: 93-99.
5. LAVALLE, C. et al. 1990. Transverse myelitis : A manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J. Rheumatol. 17: 34-37.
6. JABS, D. A. et al. 1986. Optic neuropathy in systemic lupus erythematosus. Arch. Ophthalmol. 104: 564-568.
7. ASHERSON, R. A. et al. 1987. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann. Rheum. Dis. 46: 605-611.
8. HODGES, J. R. 1987. Chorea and the lupus anticoagulant. J. Neurol. Neurosurg. Psychiatry 50: 368-369.
9. LUBBE, W. F. & E. B. WALKER. 1988. Chorea gravidarum associated with circulating lupus anticoagulant. Successful outcome of pregnancy with prednisone and aspirin therapy. Br. J. Obstet. Gynaecol. 90: 487-490.
10. ICHIKAWA, K. et al. 1980. Chorea gravidarum: Report of a fetal case with neuropathological observations. Arch. Neurol. 37: 429-432.
11. VLACHOYIANNOPOULOS, P. G., G. DIMOU & A. SIAMOPOULOU-MAVDRIDOU. 1991. Chorea as a manifestation of the antiphospholipid syndrome in childhood. Clin. Exp. Rheumatol. 9: 303-305.
12. ASHERSON, R. A. et al. 1987. Chorea in systemic lupus erythematosus and "lupus like" disease: Association with antiphospholipid antibodies. Semin. Arthritis Rheum. 16: 253-259.
13. HERING, R. et al. 1991. Antiphospholipid antibodies in migraine. Cephalalgia. 11: 19-21.
14. SHUAIB, A. et al. 1987. Migraine and antiphospholipid antibodies. Headache 29: 42-43.
15. LOVE, P. E. & S. A. SANTORO. 1990. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus (SLE) erythematosus and non-SLE disorders. Ann. Intern. Med. 112: 682-698.
16. ALARCÓN-SEGOVIA, D. et al. 1989. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68: 353-365.
17. ALARCÓN-SEGOVIA, D. et al. 1992. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin. Arthritis Rheum. 21: 275-286.
18. TAN, E. M. et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheum. 21: 275-286.
19. SNEDDON, I. B. 1965. Cerebrovascular lesions and livedo reticularis. Br. J. Dermatol. 77: 180-185.
20. PÉREZ-VÁZQUEZ, M. E. et al. 1993. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J. Rheumatol. 20: 437-442.
21. LOIZOU, S. 1985. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantization of results. Clin. Exp. Rheumatol. 62: 738-745.
22. GHARAVI, A. E. et al. 1987. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann. Rheum. Dis. 46: 1-6.
23. DELEZÉ, M., C. V. ORIA & D. ALARCÓN-SEGOVIA. 1988. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J. Rheumatol. 15: 611-615.
24. 2-glycoprotein-1 than with antiphospholipid antibodies. J. Rheumatol. 22: 1899-1906.
25. NORUŠIS, M. J. 1992. SPSS/PC+. Base System User's Guide. Version 5.0. SPSS Inc. Chicago, III.
26. 2-Glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87: 4120-4124.
27. 2-Glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179: 457-462.
28. 2-Glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J. Immunol. 154: 954-960.
29. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 93: 181-186.
30. 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. J. Rheumatol. In press.
31. ALARCÓN-SEGOVIA, D. & A. R. CABRAL. 1996. (Editorial) The antiphospholipid/cofactor syndromes. J. Rheumatol. 23: 1319-1322.
32. 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am. J. Med. 101: 472-481.